Fund Description
Reckoner BBB-B CLO ETF is an actively managed exchange-traded fund designed to generate current income while seeking capital preservation by primarily investing in a diverse portfolio of BBB- and BB-rated CLO bonds
Fund Highlights
Seeks Current Income Generation
The fund aims to provide investors with a consistent income stream
Active Management
The fund is actively managed by experienced professionals who specialize in CLO investments. This active approach allows for dynamic portfolio adjustments and strategic selection primarily of BBB- and BB-rated CLO tranches, seeking to optimize returns and manage risk in evolving market conditions
Seeks Diversified CLO Exposure
The fund seeks to invest in a diversified portfolio primarily of BBB- and BB-rated CLO tranches, offering diversification across various CLO managers and underlying loan pools
Yield (%)
| 30-Day SEC Yield
as of |
|
| Distribution Yield*
as of |
|
| Distribution Frequency | Monthly |
*Covers the period from the fund's launch on October 22 through November 28.
Fund Details
| Ticker | RCLO |
| CUSIP | 00777X488 |
| Gross Expense Ratio | 0.50% |
| Net Annual Expense Ratio | 0.50% |
| Inception Date | October 22, 2025 |
| Total Net Assets of Fund as of |
|
| Exchange | NYSE ARCA |
| Designation* | NAIC 3.B (preliminary 2026) |
| Benchmark Index | J.P. Morgan CLO High Quality Mezzanine Index |
*Preliminary NAIC Designations are the intellectual property of the National Association of Insurance Commissioners (“NAIC”) and are redistributed here under license. A Preliminary NAIC Designation is an opinion of the NAIC Securities Valuation Office (“SVO”) of the probable investment risk (as defined in the Purposes and Procedures Manual of the NAIC Investment Analysis Office) that would be assigned by the SVO to an investment if purchased by an insurance company and reported to the SVO. A Preliminary NAIC Designation is only one of the regulatory factors considered by the SVO as part of its analysis of probable regulatory treatment under the Regulatory Treatment Analysis Service (“RTAS”). A full discussion of such other regulatory factors is set forth in the RTAS Letter provided to Reckoner Capital Management (“Fund Sponsor”). A Preliminary NAIC Designation cannot be used to report the Fund to state insurance regulators. However, the purchasing insurance company may obtain an NAIC Designation for the Fund by filing the security and final documents for the Fund with the SVO. The indication of probable regulatory treatment indicated by a Preliminary NAIC Designation is not a recommendation to purchase the Fund and is not intended to convey approval or endorsement of the Fund Sponsor or the Fund by the NAIC.
Pricing Data
| Closing Price as of |
- |
| Shares Outstanding as of |
- |
| Premium/Discount as of |
- |
| 30 Day Median Bid/Ask Spread as of |
- |